Account N-((2R,3R,4S,5R)-3,5,6-Trihydroxy-1-oxo-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexan-2-yl)acetamide
- Catalog No. :
- ACBUEV973
- CAS No. :
- 32181-59-2
- Molecular Formula :
- C14H25NO11
- Molecular Weight :
- 383.35
IUPAC Name:N-((2R,3R,4S,5R)-3,5,6-trihydroxy-1-oxo-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexan-2-yl)acetamide
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$104.00Login to see priceIn stockInquiry
50mg98%$166.00Login to see priceIn stockInquiry
100mg98%$258.00Login to see priceIn stockInquiry
250mg98%$479.00Login to see priceIn stockInquiry
1g98%$1293.00Login to see priceIn stockInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | N-((2R,3R,4S,5R)-3,5,6-Trihydroxy-1-oxo-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexan-2-yl)acetamide |
|---|---|
| IUPAC Name | N-((2R,3R,4S,5R)-3,5,6-trihydroxy-1-oxo-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexan-2-yl)acetamide |
| MDL No. | MFCD00063785 |
| Molecular Formula | C14H25NO11 |
| Molecular Weight | 383.35 |
| SMILES | O([C@@]([C@@H]([C@@H](NC(C)=O)C=O)O)([C@@H](CO)O)[H])[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O |
| InChI Key | HESSGHHCXGBPAJ-ZBELOFFLSA-N |
| Synonym | beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose | Gal.beta.1-4GlcNAc | O_FULL_11000000000000_GS_484_c4 | N-[(2R,4R,5S,6R)-2,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tet |
| CAS No. | 32181-59-2 |
| PubChem CID | 9800166 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P280-P301+P312-P302+P352-P305+P351+P338
Synthetic Route by SureRoute
2. ACBUEV973 Molecular Building Block Synthetic Route
N-((2R,3R,4S,5R)-3,5,6-Trihydroxy-1-oxo-4-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexan-2-yl)acetamide
N-((2R,3R,4S,5R)-3,5,6-Trihydroxy-1-oxo-4-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexan-2-yl)acetamide
N-((2R,3R,4S,5R)-4-(((2S,3S,4S,5R,6R)-6-((((2S,3S,4S,5R,6R)-3,5-Dihydroxy-4-(((2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-((((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)-4-(((2R,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-3,5,6-trihydroxy-1-oxohexan-2-yl)acetamide